Banco Santander, S.A.
Institutional investor · Portfolio as of Q1 2019
Top Holdings356 positions
SANTANDER CONSUMER USA HDG I | 245.6M | $5.2B | 58.6% | — | — | 1 qtr | First report 0 |
Visa Inc | 1.6M | $249.8M | 2.8% | $148.12 | 0.00% | 1 qtr | First report 0 |
State Street Spdr S&p 500 Etf Trust TR UNIT | 532,872 | $150.6M | 1.7% | $253.19 | 0.00% | 1 qtr | First report 0 |
ISHARES TRUST ISHARES 0-1 YEAR TREASURY BOND ETF | 1.3M | $143.4M | 1.6% | $90.67 | 0.00% | 1 qtr | First report 0 |
Meta Platforms Inc | 663,879 | $110.7M | 1.2% | $165.11 | 0.00% | 1 qtr | First report 0 |
Vanguard Index Funds S&P 500 ETF SHS | 327,372 | $84.2M | 1.0% | $231.74 | 0.00% | 1 qtr | First report 0 |
BIOGEN INC | 355,801 | $84.1M | 0.9% | $236.38 | 0.00% | 1 qtr | First report 0 |
CHIPOTLE MEXICAN GRILL INC | 117,755 | $83.6M | 0.9% | $14.21 | 0.00% | 1 qtr | First report 0 |
Amazon.com, Inc. | 44,714 | $79.6M | 0.9% | $89.04 | 0.00% | 1 qtr | First report 0 |
Apple Inc. | 379,145 | $72M | 0.8% | $45.22 | 0.00% | 1 qtr | First report 0 |
iShares Trust CORE S&P500 ETF | 240,377 | $68.4M | 0.8% | $253.31 | 0.00% | 1 qtr | First report 0 |
Vertex Pharmaceuticals Incorporated | 354,173 | $65.2M | 0.7% | $183.95 | 0.00% | 1 qtr | First report 0 |
ITAU UNIBANCO HLDG S A | 6.3M | $55.5M | 0.6% | $4.23 | 0.00% | 1 qtr | First report 0 |
XCEL ENERGY INC | 980,900 | $55.1M | 0.6% | $45.82 | +61.01% | 1 qtr | First report 0 |
UBS GROUP AG | 4.5M | $54.6M | 0.6% | $9.20 | 0.00% | 1 qtr | First report 0 |
Microsoft Corp. | 453,915 | $53.5M | 0.6% | $110.12 | 0.00% | 1 qtr | First report 0 |
Monster Beverage Corp | 863,848 | $47.1M | 0.5% | $27.29 | 0.00% | 1 qtr | First report 0 |
VANGUARD SHORT-TERM CORPORATE BOND ETF | 597,338 | $47.1M | 0.5% | $63.62 | 0.00% | 1 qtr | First report 0 |
VALE S A SPONSORED ADS | 3.6M | $47M | 0.5% | $6.84 | 0.00% | 1 qtr | First report 0 |
VANGUARD SHORT-TERM INFLATION-PROTECTED SECURITIES ETF | 894,598 | $43.5M | 0.5% | $37.16 | 0.00% | 1 qtr | First report 0 |
Banco Santander, S.A. manages $8.9B across 356 positions as of Q1 2019. Top holdings: SC (58.6%), V (2.8%), SPY (1.7%). Fund DNA: Concentrated Value. HoldingsIntel Score: 3.5/5.0.
First quarter we have for this fund: 356 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $8.9B across 356 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR